# Sirolimus and Familial Adenomatous Polyposis (FAP)

> **NCT03095703** · PHASE2 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 4 (actual)

## Conditions studied

- Adenomatous Polyposis Coli

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT03095703
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-03
- **Primary completion:** 2018-12-10
- **Final completion:** 2018-12-10
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03095703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03095703, "Sirolimus and Familial Adenomatous Polyposis (FAP)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03095703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*